Epidemiological Study of Sepsis in China: Protocol of a Cross-sectional Survey
- PMID: 27958229
- PMCID: PMC5198532
- DOI: 10.4103/0366-6999.195474
Epidemiological Study of Sepsis in China: Protocol of a Cross-sectional Survey
Abstract
Background: Sepsis is the leading cause of death among critically ill patients. Herein, we conducted a national survey to provide data on epidemiology and treatment of sepsis in the clinical practice in China, which has no detailed epidemiological data available on sepsis.
Methods: This was a prospective cross-sectional survey from December 1, 2015 to January 31, 2016 in all provinces/municipalities of the mainland of China. The primary outcome of this study was the incidence of sepsis, and the secondary outcome was its etiology in China. Patients with sepsis admitted to the Intensive Care Units were included in this study. The demographic, physiological, bacteriological, and therapeutic data of these patients were recorded. The incidence of sepsis was estimated using the data from the sixth census in China, reported by the Chinese National Health and Family Planning Commission and the National Bureau of Statistics as the standard population. The independent risk factors for increased mortality from sepsis were calculated.
Conclusions: This study indicated the incidence and outcome of sepsis in China. It also showed the most common etiology of different sites and types of infection, which could guide empiric antibiotic therapy. Moreover, it provided information on the independent risk factors for increased mortality due to sepsis. The findings provide evidence to guide clinical management and may help improve the outcome in septic patients.
Trial registration: ClinicalTrials.gov, NCT02448472; https://clinicaltrials.gov/show/NCT02448472.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China.Crit Care Med. 2007 Nov;35(11):2538-46. doi: 10.1097/01.CCM.0000284492.30800.00. Crit Care Med. 2007. PMID: 17828034
-
[Clinical study on sepsis in 2 pediatric intensive care units in Beijing].Zhonghua Er Ke Za Zhi. 2012 Mar;50(3):178-83. Zhonghua Er Ke Za Zhi. 2012. PMID: 22801197 Chinese.
-
Prevalence and incidence of severe sepsis in Dutch intensive care units.Crit Care. 2004 Aug;8(4):R153-62. doi: 10.1186/cc2858. Epub 2004 May 14. Crit Care. 2004. PMID: 15312213 Free PMC article.
-
The epidemiology of sepsis--is Australasia different?Crit Care Resusc. 2006 Sep;8(3):219-22. Crit Care Resusc. 2006. PMID: 16930108 Review.
-
Current epidemiology of sepsis in mainland China.Ann Transl Med. 2016 Sep;4(17):324. doi: 10.21037/atm.2016.08.51. Ann Transl Med. 2016. PMID: 27713882 Free PMC article. Review.
Cited by
-
lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2.Mol Ther Nucleic Acids. 2020 Mar 6;19:97-108. doi: 10.1016/j.omtn.2019.10.028. Epub 2019 Nov 2. Mol Ther Nucleic Acids. 2020. PMID: 31830649 Free PMC article.
-
Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.Chin Med J (Engl). 2017 May 20;130(10):1139-1145. doi: 10.4103/0366-6999.205859. Chin Med J (Engl). 2017. PMID: 28485312 Free PMC article. Clinical Trial.
-
Continuous versus intermittent infusions of antibiotics for the treatment of infectious diseases: Meta-analysis and systematic review.Medicine (Baltimore). 2019 Mar;98(10):e14632. doi: 10.1097/MD.0000000000014632. Medicine (Baltimore). 2019. PMID: 30855448 Free PMC article.
-
SP1 Promotes HDAC4 Expression and Inhibits HMGB1 Expression to Reduce Intestinal Barrier Dysfunction, Oxidative Stress, and Inflammatory Response after Sepsis.J Innate Immun. 2022;14(4):366-379. doi: 10.1159/000518277. Epub 2022 Apr 22. J Innate Immun. 2022. PMID: 35780770 Free PMC article.
-
Downregulation of JKAP is correlated with elevated disease risk, advanced disease severity, higher inflammation, and poor survival in sepsis.J Clin Lab Anal. 2019 Sep;33(7):e22945. doi: 10.1002/jcla.22945. Epub 2019 Jun 17. J Clin Lab Anal. 2019. PMID: 31206807 Free PMC article.
References
-
- Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51. doi: 10.1056/NEJMra1208623. - PubMed
-
- Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: The intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2:380–6. doi: 10.1016/S2213-2600(14)70061-X. - PubMed
-
- Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–74. doi: 10.1097/CCM.0b013e31827c09f8. - PubMed
-
- Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand 2000-2012. JAMA. 2014;311:1308–16. doi: 10.1001/jama.2014.2637. - PubMed
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical